Hemab Therapeutics Holdings, Inc. (COAG) Ownership Overview
25.74% Insiders
59.37% Other Institutional Investors
2.07% ETFs
12.82% Public Companies and
Individual Investors
The ownership structure of Hemab Therapeutics Holdings, Inc. (COAG) stock is a mix of institutional, retail, and individual investors. , 25.74% is owned by Insiders, and 12.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 17, 2026 | xxxxxxxxxxxxx | $1689818 | |
May 21, 2026 | xxxxxxxxxxxxx | $119776 | |
May 14, 2026 | xxxxxxxxxxxxx | $159036 | |
May 11, 2026 | xxxxxxxxxxxxx | $1268594 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $10100750 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $5510969 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $286810870 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $26291003 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,808,627 | Institution | 16.72% | 347,483,902 | |
| 7,808,627 | Insider | 16.72% | 347,483,902 | |
| 4,180,550 | Insider | 8.95% | 186,034,475 | |
| 767,575 | Institution | 1.64% | 34,157,088 | |
| 715,791 | Institution | 1.53% | 31,852,700 | |
| 275,000 | Institution | 0.59% | 12,237,500 | |
| 150,040 | Institution | 0.32% | 6,676,780 | |
| 95,460 | Institution | 0.20% | 4,247,970 | |
| 44,705 | Institution | 0.10% | 1,989,373 | |
| 37,459 | Institution | 0.08% | 1,666,926 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 555,543 | Institution | 1.19% | 26,416,070 | |
| 203,863 | Institution | 0.44% | 9,693,686 | |
| 83,486 | Institution | 0.18% | 3,720,971 | |
| 37,320 | Institution | 0.08% | 1,663,352 | |
| 32,749 | Institution | 0.07% | 1,557,215 | |
| 11,974 | Institution | 0.03% | 533,681 | |
| 7,260 | Institution | 0.02% | 323,578 | |
| 7,116 | Institution | 0.02% | 338,366 | |
| 4,678 | Institution | 0.01% | 222,439 | |
| 2,800 | Institution | <0.01% | 124,796 |
FAQ
Who Owns Hemab Therapeutics Holdings, Inc. (COAG)?
According to the latest TipRanks data, approximately 59.37% of the company's stock is held by institutional investors, 25.74% is held by insiders, and 12.82% is held by retail investors.
What percentage of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 59.37% of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by institutional investors.
What percentage of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.82% of Hemab Therapeutics Holdings, Inc. (COAG) stock is held by retail investors.
Who owns the most shares of Hemab Therapeutics Holdings, Inc. (COAG)?
Peter Kolchinsky owns the most shares of Hemab Therapeutics Holdings, Inc. (COAG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.